Navigation Links
World-Renowned Singer Youssou NDour Launches NightWatch Program
Date:11/9/2010

NEW YORK, Nov. 9, 2010 /PRNewswire-USNewswire/ -- Malaria No More and the Lalela Project announced today their new joint effort in Senegal, NightWatch. Senegalese singer Youssou NDour and other international celebrities are taking to the African airwaves to leverage the power of celebrity voices and deliver an important nightly message about malaria.  

NightWatch is an interactive media campaign that will use radio, television and cell phone text messaging (SMS) to remind people to sleep under their mosquito net to protect themselves from malaria. The program is currently rolling out in Senegal with the help of Youssou NDour. His nightly radio message "Its 9 P.M. – Are you and your family safe under your mosquito nets tonight?" can be heard in the local language, Wolof, here: http://bit.ly/9fh8Ek.

"Using something as simple and widespread as radio to reach Senegalese families will act as a reminder that nets save lives," says singer and humanitarian Youssou NDour. "Across my country, mothers and fathers are committed to keeping their families safe from malaria and Senegal's children are hanging up their nets as part of their nightly routine."

Launched by Malaria No More and the Lalela Project, the goal of the NightWatch program is to increase life-saving mosquito net usage, minimize the incidence of malaria and therefore bring down malaria deaths in Africa, where a child dies of the disease every 45 seconds. To add more star power to the campaign, Senegalese-born musician Akon also recorded a nightly message for Senegalese radio.

"I grew up in Senegal and know what malaria can do to families there," says Akon. "I am honored to have the chance to raise awareness about the disease and be part of a program that is helping protect families in my home country."

NightWatch will provide a consistent reminder at 9 p.m., every night of the week. In conjunction with the media campaign, an edu
'/>"/>

SOURCE Malaria No More
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Interleukin Genetics and Geisinger to Collaborate on Genetic Tests to Predict Weight Loss Success
2. CRi Launches the TRIO™ Multispectral Imaging System for Multi-Analyte Investigation in Tissue
3. IntegenX Launches the Apollo 324 System for Automated DNA Library Preparation at the ASHG Meeting
4. SAFE IN COMMON Launches Global Injection Safety Website
5. Sandata Technologies Launches Enhanced Location Monitoring
6. Talecris Biotherapeutics Launches PROLASTIN®-C in Canada
7. D3 Launches New Suite of Solutions, including the First Radiation Oncology Clinical Pathways Program, at the ASTRO Annual Meeting, October 31 - November 3, 2010 in San Diego
8. Paragon Bioservices Launches Second Expansion to Celebrate its 20th Anniversary
9. Medco Launches Online Safety Net to Increase Adherence and Prevent Avoidable Medication Risks
10. Global Sources launches integrated, multi-channel offerings for three fast-growing export sectors
11. Sigma-Aldrich Launches Senior Notes Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced ... trial of Lixte,s lead compound, LB‑100, is being conducted, has ... John S. Kovach , M.D., the founder and President of ... completed at a single site. Accrual of patients, however, was ...
(Date:1/23/2015)... MONMOUTH JUNCTION, N.J. , Jan. 23, 2015 ... immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber ... surgery patients, announced the receipt of $385,642, net ... approved participant of the Technology Business Tax Certificate ...
(Date:1/23/2015)... LONDON and BOSTON , January ... structure-guided drug discovery and development company, is delighted to announce ... has been awarded to Miles Congreve (Vice President ... co-founder) and Malcolm Weir (Chief Executive Officer and ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4
... (NASDAQ: CYNO ), a leader in laser- ... applications, today announced that it has received market approval ... its Cellulaze™ Cellulite Laser Workstation.  Sales through Cynosure Korea, ... expected to begin in the first quarter of 2012. ...
... Nov. 30, 2011 Reportlinker.com announces that ... in its catalogue: Drug ... technologies,markets and companies ... The delivery of drugs to ...
Cached Medicine Technology:Cynosure's Cellulaze Cellulite Laser Work Station Receives Korean Regulatory Approval 2Cynosure's Cellulaze Cellulite Laser Work Station Receives Korean Regulatory Approval 3Cynosure's Cellulaze Cellulite Laser Work Station Receives Korean Regulatory Approval 4Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 3Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 4Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 5Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 6Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 7Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 8Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 9Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 10Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 11Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 12Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 13
(Date:1/22/2015)... 23, 2015 Recently, Weddingshe.com has added many ... has announced its highest annual revenues in the past three ... popular glamorous wedding dresses. , According to the sales manager ... dress promotions for them in 2015. This point can be ...
(Date:1/22/2015)... January 22, 2015 Payday lending practices ... communities and cause financial distress to the states that ... at Howard University’s Center on Race and Wealth. , ... economic activity, payday loans at the same time substantially ...
(Date:1/22/2015)... is a famous dress online store for wedding dresses and ... collection of wedding dresses , and launches a site-wide women’s ... dress on your big day; the wedding gown is the ... to find the most suitable wedding dress. Now, we are ...
(Date:1/22/2015)... January 22, 2015 Step into a ... the Science Museum of Virginia. Wicked Plants, the Museum’s ... Plants unearths 75 poisonous, carnivorous and diabolical plants inside ... room to uncover the biochemical, physical and neurological processes ...
(Date:12/26/2014)... 2014 It is said that nothing makes ... UWDress.com, the famous wedding dress supplier, shows its new ... cocktail gown promotion. , UWDress.com’s navy cocktail gowns are ... come in high fashion styles. Simple dresses in bright neon ...
Breaking Medicine News(10 mins):Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2
... , , SOUTH SAN ... ) today reported financial results for the second quarter and six months ... quarter of 2009, Rigel reported a net loss of $29.9 million, or ... $0.93 per share, in the second quarter of 2008. Weighted average shares ...
... , , , , ... BNVI ) today announced positive results from the Phase 1B ... advanced breast cancer. In the trial, Bezielle showed an excellent safety ... a difficult-to-treat population. , , The ...
... , , SPRING, Texas, Aug. 4 ... the nutrition and investing community that its flagship product Cholesterade(R), along ... easily accessible by simply Googling Cholesterade(R). , , ... Go Healthy and/or its products, we are confident that the web ...
... ... resources for children and adults suffering from Food Allergies and Food Intolerance issues. , ... Tampa, FL (PRWEB) August 4, 2009 ... adults in the United States. Scientists estimate over 12 million Americans suffer from Food Allergies. ...
... , , ... Ashes is played out on the cricket pitch, 2,000 English ... their prowess and behaviours at the barbecue in a poll* ... ( http://nutritionandfitness.axappphealthcare.co.uk/index.php?axacmp=pr/articles/bbq ) Despite the ...
... , , IRVINE, Calif., Aug. 4 ... of $0.49 for the quarter ended June 30, 2009, a 24% increase ... Company reported quarterly revenues of $81 million, a 4% increase compared to ... , The Company,s results are reflective of improved growth in ...
Cached Medicine News:Health News:Rigel Announces Second Quarter 2009 Financial Results 2Health News:Rigel Announces Second Quarter 2009 Financial Results 3Health News:Rigel Announces Second Quarter 2009 Financial Results 4Health News:Rigel Announces Second Quarter 2009 Financial Results 5Health News:Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer 2Health News:Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer 3Health News:Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer 4Health News:Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer 5Health News:Go Healthy's Marquis Product Cholesterade(R) at Your Fingertips on Google 2Health News:New Online Solution for Food Allergy Sufferers. Allergiesandme.com Provides Needed Resources 2Health News:Survey Compares Aussie and English Barbeque Attitudes 2Health News:Survey Compares Aussie and English Barbeque Attitudes 3Health News:CorVel Announces Revenues and Earnings 2Health News:CorVel Announces Revenues and Earnings 3Health News:CorVel Announces Revenues and Earnings 4Health News:CorVel Announces Revenues and Earnings 5
... IEC CL30 Series from Thermo ... value for your low-speed clinical ... rotor exchange system, user-friendly controls, ... IEC CL30 Series delivers solid ...
... and FL40 Centrifuge Series from Thermo ... to increase your productivity in the ... of rotors and accessories for high-volume ... the IEC CL40 and FL40 Centrifuge ...
... CL10 from Thermo is ... your low-speed clinical applications. ... of rotors, user-friendly controls, ... the IEC CL10 delivers ...
Chembio Diagnostic Systems, Inc.s SURE CHECK HIV 1 / 2, HIV 1/ 2 STAT-PAK and HIV 1/ 2 STAT-PAK Dipstick tests are easy-to-perform, single-use diagnostic tests for the rapid, visual detection of anti...
Medicine Products: